Talk Title: Quantitative Proteomics in wellness and disease settings
Dr. Robert Moritz is Faculty member and Head of Proteomics Research at the Institute for Systems Biology (ISB) in Seattle Washington.
He began his career at the Ludwig Institute for Cancer Research, Melbourne, Australia in 1983 and moved to the ISB as faculty member in 2008.
His research interests in proteomics include the discovery of normal and disease markers using targeted quantitative mass spectrometry. Specifically, his group develops proteomics tools and applies these to biomarker studies for infectious diseases, lung abnormalities and other human diseases such as kidney disease, diabetes and cancer.
The Moritz group is a primary developer of proteomics software tools and pipelines for statistical validation of proteome identifications such as the world renowned Trans-Proteomic Pipeline, protein crosslinking interpretation with the program suite Kojak and online resources for quantitative proteomics under the PeptideAtlas resource. His group has developed the complete Human Peptide- and SRM-Atlas, the SWATHAtlas and software routines for SWATH data analysis to provide quantitative resources and community driven repositories of mass spectrometric assays to all proteins.
Dr. Moritz is currently the Vice-President of the Human Proteome Organization (HUPO) and plays a large role in growing the society. He has authored more than 230 papers and holds several patents in technology development and discovery protein science of the relationship of aberrant protein expression. Dr. Moritz is active in teaching and dissemination of proteomics technologies fosters education exchanges and create forums for collaborative relationships centered on the human proteome.